|
Iyú D, Jüttner M, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S. PGE1 and PGE2 modify platelet function through different prostanoid receptors. Prostaglandins Other Lipid Mediat. 2011 Feb;94(1-2):9-16. doi: 10.1016/j.prostaglandins.2010.11.001. Epub 2010 Nov 21. PubMed PMID: 21095237.
AÑO: 2011; IF: 2.705
|
21095237
|
Iyú D, Glenn JR, White AE, Fox SC, van Giezen H, Nylander S, Heptinstall S. Mode of action of P2Y(12 ) antagonists as inhibitors of platelet function. Thromb Haemost. 2011 Jan;105(1):96-106. doi: 10.1160/TH10-07-0482. Epub 2010 Oct 12. PubMed PMID: 20941457.
AÑO: 2011; IF: 5.044
|
|
Iyú D, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Platelets. 2010;21(5):329-42. doi: 10.3109/09537101003718065. PubMed PMID: 20433310.
AÑO: 2010; IF: 2.117
|
|
Alcaraz A, Hernández D, Iyú D, Mota R, Atucha NM, Ortiz AJ, García-Estañ J, Ortiz MC. Effects of chronic L-NAME on nitrotyrosine expression and renal vascular reactivity in rats with chronic bile-duct ligation. Clin Sci (Lond). 2008 Jul;115(2):57-68. doi: 10.1042/CS20070312. PubMed PMID: 18184108.
AÑO: 2008; IF: 4.187
|
|
Heptinstall S, Espinosa DI, Manolopoulos P, Glenn JR, White AE, Johnson A, Dovlatova N, Fox SC, May JA, Hermann D, Magnusson O, Stefansson K, Hartman D, Gurney M. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 2008 Dec;19(8):605-13. doi: 10.1080/09537100802351073. PubMed PMID: 19012178.
AÑO: 2008; IF: 2.271
|